Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Multiple Sclerosis | Research

The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial

Authors: Penelope Smyth, Kaitlyn E. Watson, Yazid N. Al Hamarneh, Ross T. Tsuyuki

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Care for People with Multiple Sclerosis (PwMS) is increasingly complex, requiring innovations in care. Canada has high rates of MS; it is challenging for general neurologists to optimally care for PwMS with busy office practices. The aim of this study was to evaluate the effects of add-on Nurse Practitioner (NP)-led care for PwMS on depression and anxiety (Hospital Anxiety and Depression Scale, HADS), compared to usual care (community neurologist, family physician).

Methods

PwMS followed by community neurologists were randomized to add-on NP-led or Usual care for 6 months. Primary outcome was the change in HADS at 3 months. Secondary outcomes were HADS (6 months), EQ5D, MSIF, CAREQOL-MS, at 3 and 6 months, and Consultant Satisfaction Survey (6 months).

Results

We recruited 248 participants; 228 completed the trial (NP-led care arm n = 120, Usual care arm n = 108). There were no significant baseline differences between groups. Study subjects were highly educated (71.05%), working full-time (41.23%), living independently (68.86%), with mean age of 47.32 (11.09), mean EDSS 2.53 (SD 2.06), mean duration since MS diagnosis 12.18 years (SD 8.82) and 85% had relapsing remitting MS. Mean change in HADS depression (3 months) was: -0.41 (SD 2.81) NP-led care group vs 1.11 (2.98) Usual care group p = 0.001, sustained at 6 months; for anxiety, − 0.32 (2.73) NP-led care group vs 0.42 (2.82) Usual care group, p = 0.059. Other secondary outcomes were not significantly different. There was no difference in satisfaction of care in the NP-led care arm (63.83 (5.63)) vs Usual care (62.82 (5.45)), p = 0.194).

Conclusion

Add-on NP-led care improved depression compared to usual neurologist care and 3 and 6 months in PwMS, and there was no difference in satisfaction with care. Further research is needed to explore how NPs could enrich care provided for PwMS in healthcare settings.

Trial registration

Retrospectively registered on clinicaltrials.​gov (ClinicalTrials.​gov Identifier: NCT04388592, 14/05/2020).
Appendix
Available only for authorised users
Literature
1.
Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83(11):1022–4.PubMedPubMedCentralCrossRef
2.
3.
Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler. 2020;26(14):1816–1821.2020.PubMedPubMedCentralCrossRef
4.
Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752–9.PubMedCrossRef
5.
Members of the MS in the 21st Century Steering Group, Rieckmann P, Centonze D, Elovaara I, Giovannoni G, Havrdova E, et al. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group. Mult Scler Relat Disord. 2018;19:153–60.CrossRef
6.
Meehan M, Doody O. The role of the clinical nurse specialist multiple sclerosis, the patients' and families' and carers' perspective: an integrative review. Mult Scler Relat Disord. 2020;39:101918.PubMedCrossRef
7.
Soelberg Sorensen P, Giovannoni G, Montalban X, Thalheim C, Zaratin P, Comi G. The multiple sclerosis care unit. Mult Scler. 2019;25(5):627–36.PubMedCrossRef
8.
Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, et al. International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler. 2019;25(13):1809–18.PubMedCrossRef
9.
Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G, et al. Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord. 2016;9(Suppl 1):S5–S48.PubMedCrossRef
10.
Petrin J, McColl MA, Donnelly C, French S, Finlayson M. Prioritizing the healthcare access concerns of Canadians with MS. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211029672.PubMedPubMedCentral
11.
Borreani C, Bianchi E, Pietrolongo E, Rossi I, Cilia S, Giuntoli M, et al. Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention. PLoS One. 2014;9(10):e109679.PubMedPubMedCentralCrossRef
12.
Buchanan RJ, Huang C. Informal caregivers assisting people with multiple sclerosis: factors associated with the strength of the caregiver/care recipient relationship. Int J MS Care. 2011;13(4):177–87.PubMedPubMedCentralCrossRef
13.
Holland NJ, Schneider DM, Rapp R, Kalb RC. Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community. Int J MS Care. 2011;13(2):65–74.PubMedPubMedCentralCrossRef
14.
Le Fort M, Wiertlewski S, Bernard I, Bernier C, Bonnemain B, Moreau C, et al. Multiple sclerosis and access to healthcare in the pays de la Loire region: preliminary study based on 130 self-applied double questionnaires. Ann Phys Rehabil Med. 2011;54(3):156–71.PubMedCrossRef
15.
Lorefice L, Mura G, Coni G, Fenu G, Sardu C, Frau J, et al. What do multiple sclerosis patients and their caregivers perceive as unmet needs? BMC Neurol. 2013;13:177.PubMedPubMedCentralCrossRef
16.
Matti AI, McCarl H, Klaer P, Keane MC, Chen CS. Multiple sclerosis: patients' information sources and needs on disease symptoms and management. Patient Prefer Adherence. 2010;4:157–61.PubMedPubMedCentralCrossRef
17.
Mehr SR, Zimmerman MP. Reviewing the unmet needs of patients with multiple sclerosis. Am Health Drug Benefits. 2015;8(8):426–31.PubMedPubMedCentral
18.
Ponzio M, Tacchino A, Zaratin P, Vaccaro C, Battalglia MA. Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on multiple sclerosis. Eur J Pub Health. 2015;25(5):775–80.CrossRef
19.
Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G, et al. The changing face of multiple sclerosis: prevalence and incidence in an aging population. Mult Scler. 2015;21(10):1244–50.PubMedCrossRef
20.
Strupp J, Romotzky V, Galushko M, Golla H, Voltz R. Palliative care for severely affected patients with multiple sclerosis: when and why? Results of a Delphi survey of health care professionals. J Palliat Med. 2014;17(10):1128–36.PubMedPubMedCentralCrossRef
21.
Young L, Healey K, Charlton M, Schmid K, Zabad R, Wester R. A home-based comprehensive care model in patients with Multiple Sclerosis: A study pre-protocol. F1000Res. 2015;4:872.PubMedPubMedCentralCrossRef
22.
Ponzio M, Tacchino A, Vaccaro C, Brichetto G, Battaglia MA, Messmer UM. Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis. Neurol Sci. 2019;40(6):1137–44.PubMedCrossRef
23.
Ponzio M, Tacchino A, Vaccaro C, Traversa S, Brichetto G, Battaglia MA, et al. Unmet needs influence health-related quality of life in people with multiple sclerosis. Mult Scler Relat Disord. 2020;38:101877.PubMedCrossRef
24.
Forbes A, While A, Taylor M. What people with multiple sclerosis perceive to be important to meeting their needs. J Adv Nurs. 2007;58(1):11–22.PubMedCrossRef
25.
Petrin J, Finlayson M, Donnelly C, McColl MA. Healthcare access experiences of persons with MS explored through the candidacy framework. Health Soc Care Community. 2021;29(3):789–99.PubMedCrossRef
26.
Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia. Canada J Neurol Neurosurg Psychiatry. 2012;83(1):61–6.PubMedCrossRef
27.
Martin-Misener R, Harbman P, Donald F, Reid K, Kilpatrick K, Carter N, et al. Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review. BMJ Open. 2015;5(6):e007167.PubMedPubMedCentralCrossRef
28.
Schuttelaar ML, Vermeulen KM, Drukker N, et al. A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. Br J Dermatol. 2010;162(1):162–70.PubMedCrossRef
29.
Schuttelaar ML, Vermeulen KM, Coenraads PJ. Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol. 2011;165(3):600–11.PubMedCrossRef
30.
Limoges-Gonzalez M, Mann NS, Al-Juburi A, Tseng D, Inadomi J, Rossaro L. Comparisons of screening colonoscopy performed by a nurse practitioner and gastroenterologists: a single-center randomized controlled trial. Gastroenterol Nurs. 2011;34(3):210–6.PubMedCrossRef
31.
Allen JK, Blumenthal RS, Margolis S, Young DR, Millier ER 3rd, Kelly K. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Am Heart J. 2002;144(4):678–86.PubMedCrossRef
32.
Paez KA, Allen JK. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization. J Amer Acad of Nurs Pract. 2006;18(9):436–44.CrossRef
33.
Krein SL, Klamerus ML, Vijan S, Lee JL, Fitzgerald JT, Pawlow A, et al. Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med. 2004;116(11):732–9.PubMedCrossRef
34.
Litaker D, Mion L, Planavsky L, Kippes C, Mehta N, Frolkis J. Physician - nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. J Interprof Care. 2003;17(3):223–37.PubMedCrossRef
35.
van der Marck MA, Bloem BR, Borm GF, Overeem S, Munneke M, Guttman M. Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial. Mov Disord. 2013;28(5):605–11.PubMedCrossRef
36.
Smyth P, Watson KE, Tsuyuki RT. Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial. Trials. 2021;22(1):785.PubMedPubMedCentralCrossRef
37.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.PubMedPubMedCentralCrossRef
38.
Kuspinar A, Mayo NE. A review of the psychometric properties of generic utility measures in multiple sclerosis. Pharmacoeconomics. 2014;32(8):759–73.PubMedCrossRef
39.
Ziemssen T. Symptom management in patients with multiple sclerosis. J Neurol Sci. 2011;311(Suppl 1):S48–52.PubMedCrossRef
40.
Crabtree-Hartman E. Advanced symptom Management in Multiple Sclerosis. Neurol Clin. 2018;36(1):197–218.PubMedCrossRef
41.
Honarmand K, Feinstein A. Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Mult Scler. 2009;15(12):1518–24.PubMedCrossRef
42.
Puhan MA, Frey M, Büchi S, Schunemann HJ. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008;6:46.PubMedPubMedCentralCrossRef
43.
Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79–83.PubMedCrossRef
44.
Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994;21(1):9–14.PubMedCrossRef
45.
Shaida N, Jones C, Ravindranath N, Das T, Wilmott K, Jones A, et al. Patient satisfaction with nurse-led telephone consultation for the follow-up of patients with prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(4):369–73.PubMedCrossRef
46.
Baker R. Development of a questionnaire to assess patients' satisfaction with consultations in general practice. Br J Gen Pract. 1990;40(341):487–90.PubMedPubMedCentral
47.
48.
Smigorowsky MJ, Norris CM, McMurtry MS, Tsuyuki RT. Measuring the effect of nurse practitioner (NP)-led care on health-related quality of life in adult patients with atrial fibrillation: study protocol for a randomized controlled trial. Trials. 2017;18(1):364.PubMedPubMedCentralCrossRef
49.
Kuspinar A, Rodriguez AM, Mayo NE. The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis. Mult Scler. 2012;18(12):1686–704.PubMedCrossRef
50.
Janssens AC, van Doorn PA, de Boer JB, Kalkers NF, van der Meche FG, Passchier J, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler. 2003;9(4):397–403.PubMedCrossRef
51.
Brenner P, Piehl F. Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions. Acta Neurol Scand. 2016;134(Suppl 200):47–54.PubMedCrossRef
52.
McKay KA, Tremlett H, Fisk JD, Zhang T, Patten SB, Kastrukoff L, et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. 2018;90(15):e1316–23.PubMedPubMedCentralCrossRef
53.
McKay KA, Ernstsson O, Manouchehrinia A, Olsson T, Hillert J. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis. Neurology. 2020;94(9):e932–41.PubMedPubMedCentralCrossRef
54.
Biernacki T, Sandi D, Kincses ZT, Fuvesi J, Rozsa C, Matyas K, et al. Contributing factors to health-related quality of life in multiple sclerosis. Brain Behav. 2019;9(12):e01466.PubMedPubMedCentralCrossRef
55.
Pugliatti M, Riise T, Nortvedt MW, Carpentras G, Sotgiu MA, Sotgui S, et al. Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol. 2008;255(2):157–62.PubMedCrossRef
56.
Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol. 1992;49(12):1237–42.PubMedCrossRef
57.
Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, et al. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. Gen Hosp Psychiatry. 2018;53:65–72.PubMedCrossRef
58.
Marrie RA, Patten SB, Berrigan LI, Tremlett H, Wolfson C, Warren S, et al. Diagnoses of depression and anxiety versus current symptoms and quality of life in multiple sclerosis. Int J MS Care. 2018;20(2):76–84.PubMedPubMedCentralCrossRef
59.
Forbes A, While A, Dyson L, Grocott T, Griffiths P. Impact of clinical nurse specialists in multiple sclerosis--synthesis of the evidence. J Adv Nurs 2003;42(5):442–462.
60.
Maloni HW. Multiple sclerosis: managing patients in primary care. Nurse Pract. 2013;38(4):24–35 quiz 35-26.PubMedCrossRef
61.
Maloni H, Hillman L. Multidisciplinary Management of a Patient with Multiple Sclerosis: part 2. Nurses’ Perspective Fed Pract. 2015;32(Suppl 3):17S–9S.PubMed
62.
Roman C, Menning K. Treatment and disease management of multiple sclerosis patients: a review for nurse practitioners. J Am Assoc Nurse Pract. 2017;29(10):629–38.PubMedCrossRef
63.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler. 2018;24(2):96–120.PubMedCrossRef
64.
Patten SB, Marrie RA, Carta MG. Depression in multiple sclerosis. Int Rev Psychiatry. 2017;29(5):463–72.PubMedCrossRef
65.
Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12–26.PubMedCrossRef
66.
Hind D, Cotter J, Thake A, Bradburn M, Cooper C, Isaac C, et al. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:5.PubMedPubMedCentralCrossRef
67.
Kidd T, Carey N, Mold F, Westwood S, Miklaucich M, Konstantara E, et al. A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life. PLoS One. 2017;12(10):e0185931.PubMedPubMedCentralCrossRef
68.
Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.PubMedCrossRef
69.
Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159(11):1862–8.PubMedCrossRef
70.
Zabad RK, Patten SB, Metz LM. The association of depression with disease course in multiple sclerosis. Neurology. 2005;64(2):359–60.PubMedCrossRef
71.
Koch MW, Patten S, Berzins S, Zhornitsky S, Greenfield J, Wall W, et al. Depression in multiple sclerosis: a long-term longitudinal study. Mult Scler. 2015;21(1):76–82.PubMedCrossRef
72.
Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305–17.PubMedPubMedCentralCrossRef
73.
Raissi A, Bulloch AG, Fiest KM, McDonald K, Jette N, Patten SB. Exploration of Undertreatment and patterns of treatment of depression in multiple sclerosis. Int J MS Care. 2015;17(6):292–300.PubMedPubMedCentralCrossRef
74.
Trilla F, DeCastro T, Harrison N, Mowry D, Croke A, Bicket M, et al. Nurse practitioner home-based primary care program improves patient outcomes. J Nurse Pract. 2018;14:e185–8.CrossRef
75.
Melnick G, Green L, Rich J. House calls: California program for homebound patients reduces monthly spending, delivers meaningful care. Health Aff (Millwood). 2016;35(1):28–35.CrossRef
76.
77.
Lonergan R, Kinsella K, Fitzpatrick P, Duggan M, Jordan S, Bradley D, et al. Unmet needs of multiple sclerosis patients in the community. Mult Scler Relat Disord. 2015;4(2):144–50.PubMedCrossRef
78.
Pétrin J, Donnelly C, McColl MA, Finlayson M. Is it worth it?: the experiences of persons with multiple sclerosis as they access health care to manage their condition. Health Expect. 2020;23(5):1269–79.PubMedPubMedCentralCrossRef
79.
McCabe MP, Ebacioni KJ, Simmons R, McDonald E, Melton L. Unmet education, psychological and peer support needs of people with multiple sclerosis. J Psychosom Res. 2015;78(1):82–7.PubMedCrossRef
80.
81.
Buchanan R, Huang C. Health-related quality of life among informal caregivers assisting people with multiple sclerosis. Disabil Rehabil. 2011;33(2):113–21.PubMedCrossRef
82.
83.
84.
85.
Leary A, Quinn D, Bowen A. Impact of proactive case management by multiple sclerosis specialist nurses on use of unscheduled care and emergency presentation in multiple sclerosis: a case study. Int J MS Care. 2015;17(4):159–63.PubMedPubMedCentralCrossRef
86.
Papeix C, Gambotti L, Assouad R, Ewencyck C, Tanguy ML, Pineau F, et al. Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: a prospective, randomized, controlled study. Mult Scler J. 2015;1:2055217315608864.
87.
Wynia K, Annema C, Nissen H, De Keyser J, Middel B. Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled multiple sclerosis patients. BMC Health Serv Res. 2010;10:142.PubMedPubMedCentralCrossRef
Metadata
Title
The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial
Authors
Penelope Smyth
Kaitlyn E. Watson
Yazid N. Al Hamarneh
Ross T. Tsuyuki
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02809-9

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue

Research

A multicentre retrospective cohort study on health-related quality of life after traumatic acute subdural haematoma: does cranial laterality affect long-term recovery?

Case report

Moyamoya associated with Turner syndrome in a patient with type 2 spinocerebellar ataxia—Occam’s razor or Hickam’s dictum: a case report

Research

Clinical features, etiology, and prognosis of hand knob stroke: a case series

Case report

Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient

Study protocol

Stent-assisted coiling of acutely ruptured cerebral aneurysm: a multicenter prospective registry study (SAVE)

Study protocol

Optimizing Prehospital Stroke Systems of Care-Reacting to Changing Paradigms (OPUS-REACH): a pragmatic registry of large vessel occlusion stroke patients to create evidence-based stroke systems of care and eliminate disparities in access to stroke care